Table of contents

Rheumatoid arthritis

Concise report

• Concise report: Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry (30 June, 2015)

  J H Salmon, P Cacoub, B Combe, J Sibilia, B Pallot-Prades, O Fain, A Cantagrel, M Dougados, E Andres, O Meyer, P Carli, E Pertuiset, I Pane, F Maurier, P Ravaud, X Mariette, J E Gottenberg
• Concise report: The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries (30 April, 2015)

  A Finckh, D Neto, F Iannone, E Loza, E Lie, P van Riel, M L Hetland, K Pavelka, J E Gottenberg, H Canhão, X Mariette, C Turesson

Extended report

• Extended report: What is the prevalence of MRI-detected inflammation and erosions in small joints in the general population? A collation and analysis of published data (18 February, 2015)

  Lukas Mangnus, Jan W Schoones, Annette H M van der Helm-van Mil
• Concise report: Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy (20 February, 2015)

  Johanna Callhoff, Katinka Albrecht, Georg Schett, Angela Zink, Gisela Westhoff
• Extended report: Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study (4 March, 2015)

  Hanna W van Steenbergen, Roula Tsonaka, Tom W J Huizinga, Annelies Boonen, Annette H M van der Helm-van Mil
• Extended report: Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study (8 April, 2015)

  Wei Zhang, Nick Bansback, Huiying Sun, Ronald Pedersen, Sameer Kotak, Aslam H Anis
• Extended report: The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region (28 April, 2015)

  X Mariette, J Vencovsky, O Lortholary, J Gomez-Reino, M de Longueville, P Ralston, M Weinblatt, R van Vollenhoven
• Extended report: Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population (29 April, 2015)

  Boulos Haraoui, Algis Jovaisas, William G Bensen, Rafat Faraawi, John Kelsall, Sanjay Dixit, Jude Rodrigues, Maqbool Sheriff, Emmanouil Rampakakis, John S Sampalis, Allen J Lehman, Susan Otawa, Francois Nantel, May Shawi
• Extended report: Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis (21 May, 2015)

  Michael Nurmohamed, Yanjun Bao, James Signorovitch, Alex Trahey, Parvez Mulani, Daniel E Furst
• Extended report: Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatment (28 July, 2015)

  B Fautrel, H W Nab, Y Brault, G Gallo
• Extended report: Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study (12 August, 2015)

  Michael Schiff, Bernard Combe, Thomas Dörner, Joel M Kremer, Thomas W Huizinga, Melissa Veenhuizen, Anne Gill, Wendy Komocsar, Pierre-Yves Berclaz, Robert Ortmann, Chin Lee
• Extended report: Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis (13 August, 2015)

  Rieke Alten, Amy Grahn, Robert J Holt, Patricia Rice, Frank Buttgereit
• Extended report: Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors? (18 November, 2015)

  Sofia Ramiro, Robert Landewé, Désirée van der Heijde, David Harrison, David Collier, Kaleb Michaud
• Extended report: A new classification of HLA-DRB1 alleles based on acid–base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort) (19 November, 2015)

  Adeline Ruyssen-Witrand, Hanna W van Steenbergen, Jurgen van Heemst, Pierre-Antoine Gourraud, Delphine Nigon, Cédric Lukas, Corinne Miceli-Richard, Bénédicte Jamard, Anne Cambon-Thomsen, Alain Cantagrel, Philippe Dieudé, Annette H M van der Helm-van Mil, Arnaud Constantin
• Extended report: Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare (19 November, 2015)

  Jos Hendrikx, Jaap Fransen, Piet L C M van Riel
• Extended report: Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis (9 December, 2015)

  Yinghe Huo, Maria J H De Hair, Yasmin O Shaib, Désirée van der Heijde, Natalia O Kuchuk, Max A Viergever, Jacob M van Laar, Koen L Vincken, Floris P Lafeber

Recommendation

• Recommendation: Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry (8 October, 2015)

  Sofie H M Manders, Mart A F J van de Laar, Sanne A A Rongen-van Dartel, Reinhard Bos, Henk Visser, Herman L Brus, Tim Jansen, Harald E Vonkeman, Piet L C M van Riel, Wietske Kievit

Review

• Review: Genetics of RA susceptibility, what comes next? (15 April, 2015)

  James Ding, Stephen Eyre, Jane Worthington
• Review: Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis (2 April, 2015)

  Laure Gossec, Maxime Dougados, William Dixon
• Review: Biosimilars in rheumatology: what the clinician should know (23 May, 2015)

  Gilberto Castañeda-Hernández, Rodrigo González-Ramírez, Jonathan Kay, Morton A Scheinberg
• Review: Biologicals in rheumatoid arthritis: current and future (5 August, 2015)

  Ali Berkant Avci, Eugen Feist, Gerd-R Burmester